Pharmaceutical Industry Trends & News - Pharmaceutical Technology

PremiumFeatures

GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic

Improving outcomes for patients classed as ‘non-responders’ remains a key unmet need within the obesity space.

Annabel Kartal Allen

News

Scientists claim Nobel Prize for approach behind light-activated gene therapy

Annabel Kartal Allen

News

AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact

Annabel Kartal Allen

News

FDA approves expanded indication for Lilly’s Jaypirca

News

Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US

Features

Magazine: Keep it cool

PremiumNews

Novartis bets on autoimmune BiTEs through $7.8bn Abogen deal

News

Sanofi and Regeneron expand immunology partnership to the tune of $8bn

Analysis

PremiumAnalyst Comment

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

GlobalData Healthcare

PremiumAnalyst Comment

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

GlobalData Healthcare

PremiumAnalyst Comment

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

GlobalData Healthcare

PremiumAnalyst Comment

China expands its manufacturing role for biopharma’s new drugs

GlobalData Healthcare

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Bio/Pharmaceutical Outsourcing Report, August 2026

$2950.00

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

$3495.00

Hodgkin Lymphoma: Epidemiology Report and Forecast to 2035

$9995.00

Glioblastoma (GBM): Epidemiology Report and Forecast to 2035

$9995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Scientists claim Nobel Prize for approach behind light-activated gene therapy

AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact

FDA approves expanded indication for Lilly’s Jaypirca

Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US

Magazine: Keep it cool

Novartis bets on autoimmune BiTEs through $7.8bn Abogen deal

Sanofi and Regeneron expand immunology partnership to the tune of $8bn

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

China expands its manufacturing role for biopharma’s new drugs

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Bio/Pharmaceutical Outsourcing Report, August 2026

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast to 2035

Glioblastoma (GBM): Epidemiology Report and Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Bio/Pharmaceutical Outsourcing Report, August 2026

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast to 2035

Glioblastoma (GBM): Epidemiology Report and Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing